SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 223 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $720 | -81.9% | 2,000 | -55.6% | 0.00% | – |
| Q4 2022 | $3,987 | -43.0% | 4,500 | 0.0% | 0.00% | – |
| Q3 2022 | $7,000 | -22.2% | 4,500 | 0.0% | 0.00% | – |
| Q2 2022 | $9,000 | -10.0% | 4,500 | 0.0% | 0.00% | – |
| Q1 2022 | $10,000 | -52.4% | 4,500 | 0.0% | 0.00% | – |
| Q4 2021 | $21,000 | -52.3% | 4,500 | -22.4% | 0.00% | -100.0% |
| Q3 2021 | $44,000 | -21.4% | 5,798 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $56,000 | -100.0% | 5,798 | -64.6% | 0.00% | 0.0% |
| Q1 2021 | $135,594,000 | +294669.6% | 16,396 | +141.2% | 0.00% | 0.0% |
| Q4 2020 | $46,000 | -39.5% | 6,798 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $76,000 | +245.5% | 6,798 | +94.2% | 0.00% | +100.0% |
| Q2 2020 | $22,000 | – | 3,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 2,186,520 | $38,526,000 | 10.61% |
| Cormorant Asset Management, LP | 1,945,334 | $34,277,000 | 4.56% |
| Aisling Capital LLC | 1,703,855 | $30,022,000 | 4.47% |
| Wildcat Capital Management, LLC | 736,012 | $12,968,000 | 4.44% |
| ACUTA CAPITAL PARTNERS, LLC | 212,402 | $3,743,000 | 2.31% |
| Healthcare Value Capital, LLC | 50,000 | $881,000 | 0.92% |
| EAM Investors, LLC | 249,028 | $4,388,000 | 0.51% |
| TFS CAPITAL LLC | 150,812 | $2,657,000 | 0.26% |
| GAGNON SECURITIES LLC | 11,001 | $194,000 | 0.08% |
| Granite Investment Partners, LLC | 43,861 | $772,000 | 0.07% |